|
Leadership Team |
|
 |
Salvatore Calabrese Chief Financial Officer Salvatore Calabrese serves as Chief Financial Officer of Gain Therapeutics. He joined the company in 2020 with more than 24 years of experience in finance and accounting leadership. Prior to joining Gain, Mr. Calabrese served as the chief financial officer of Molmed, a public reporting cell & gene company. He developed his career as general manager and site leader for the Italian operation of Jazz Pharmaceuticals and at Gentium covering various roles including chief operating officer, chief financial officer, senior vice president of finance and vice president of finance. Mr. Calabrese has also served as an accounting and finance manager for Novuspharma, a development stage biopharmaceutical company focused on the discovery and development of cancer drugs and a subsidiary of Cell Therapeutics, a public reporting company, which then merged into Cell Therapeutics. Mr. Calabrese was also employed by PricewaterhouseCoopers as an accountant and was a manager in Assurance Business Advisory Services at the time of his departure. He is listed in the Italian National Audit Register held by the National Justice Department in the Republic of Italy. Mr. Calabrese received a B.A. in Economics from the University of Messina and a Masters’ Degree in Accounting, Audit and Financial Control from the University of Pavia.
|
Salvatore Calabrese
Partners |
|
Grants |
 |
 |
 |
 |
|
Patient Associations |
 |
 |
 |
 |
|
Centers of Research, Translational Science & Clinical Excellence |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Interested in working with a dynamic team of research, |